¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"principal cell"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
antibody-producing cell
Ç×ü»ý»ê¼¼Æ÷
antibody-screening cell
Ç×ü¼±º°Ç÷±¸
antigen-presenting cell
Ç׿øÁ¦½Ã¼¼Æ÷
antigen-reactive cell
Ç׿ø¹ÝÀÀ¼¼Æ÷
antigen-recognizing cell
Ç׿øÀÎÁö¼¼Æ÷
argentaffin cell
ÀºÄ£È¼¼Æ÷
argyrophilic cell
ÀºÄ£È¼¼Æ÷
asexual cell
¹«¼º¼¼Æ÷
acidophilic cell
È£»ê¼¼Æ÷
acinar cell
»ù²Ê¸®¼¼Æ÷, ¼¼¿±¼¼Æ÷
acinar cell carcinoma
»ù²Ê¸®¼¼Æ÷¾ÏÁ¾, ¼¼¿±¼¼Æ÷¾ÏÁ¾
acinic cell carcinoma
»ù²Ê¸®¼¼Æ÷¾ÏÁ¾, ¼¼¿±¼¼Æ÷¾ÏÁ¾
adult T-cell leukemia/lymphoma
¼ºÀÎT¼¼Æ÷¹éÇ÷º´/¸²ÇÁÁ¾
amacrine cell
¹«Ãà»è¼¼Æ÷
ameboid cell
¾Æ¸Þ¹Ù¸ð¾ç¼¼Æ÷
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ethmoidal cell
¹úÁý»À¹úÁý
eukaryotic cell
ÁøÇÙ¼¼Æ÷
goblet cell
¼úÀܼ¼Æ÷
hair cell
Åм¼Æ÷
inflammatory cell
¿°Áõ¼¼Æ÷
killer cell
»ìÇØ¼¼Æ÷
Kupffer's cell
º°Å«Æ÷½Ä¼¼Æ÷, ÄíÆÛ¼¼Æ÷
mast cell
ºñ¸¸¼¼Æ÷
mesenchymal cell
Áß°£¿±¼¼Æ÷
mesothelial cell
ÁßÇǼ¼Æ÷
mother cell
¸ð¼¼Æ÷, ¾î¹Ì¼¼Æ÷
neuroendocrine cell
½Å°æ³»ºÐºñ¼¼Æ÷
packed red blood cell
³óÃàÀûÇ÷±¸
parietal cell
º®¼¼Æ÷
perivascular cell
Ç÷°üÁÖÀ§¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
acidophilic cell
È£»ê¼º¼¼Æ÷
acinar cell
»ù²Ê¸®¼¼Æ÷
acinic cell carcinoma
»ù²Ê¸®¼¼Æ÷¾ÏÁ¾, ¼¼¿±¼¼Æ÷¾ÏÁ¾
amacrine cell
¹«Ãà»è¼¼Æ÷
ameboid cell
¾Æ¸Þ¹Ù¸ð¾ç¼¼Æ÷
annular elastotic giant cell granuloma
°í¸®Åº·Â¼¶À¯°Å´ë¼¼Æ÷À°¾ÆÁ¾, ȯ»óź·Â¼¶À¯°Å´ë¼¼Æ÷À°¾ÆÁ¾
antibody-dependent cell-mediated cytotoxicity
Ç×üÀÇÁ¸¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º
antibody-producing cell
Ç×ü»ý»ê¼¼Æ÷
antibody-screening cell
Ç×ü¼±º°Ç÷±¸
antigen-presenting cell
Ç׿øÀü´Þ¼¼Æ÷
antigen-reactive cell
Ç׿ø¹ÝÀÀ¼¼Æ÷
antigen-recognizing cell
Ç׿øÀÎÁö¼¼Æ÷
argentaffin cell
ģũ·ÒÀº¼¼Æ÷
argyrophilic cell
ÀºÄ£È¼¼Æ÷
asexual cell
¹«¼º¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
principal point
ÁÖÁ¡(ñ«ïÇ) ½ÃÃà(ãÊõî)ÀÇ .
principal point
ÁÖÁ¡
principal quantum number
ÁÖ¾çÀÚ¼ö(ñ«åÖ íâ¦).
principal reaction
ÁÖ¹ÝÀÀ(ñ«Úãëë).
principal series
ÁÖ°è¿(Ì¡ËËç).
principal strain
ÁÖº¯Çü(ñ«Ü¨û¡).
principal stress
ÁÖº¯Çü·Â, ÁÖÀÀ·Â(ñ«ëëæ³).
principal tangential line
ÁÖÁ¢¼±°î¼±(ñ«ïÈàÊÍØàÊ).
principal valency
ÁÖ¿øÀÚ°¡(ñ«ê«íʤ).
principal value of strain
¿ÖÁÖÄ¡(èàñ«öÇ).
NK cell [=natural killer cell]
ÀÚ¿¬»ì»ó¼¼Æ÷
alpha cell glucagon cell
¾ËÆÄ¼¼Æ÷ ±Û·çÄ«°ï¼¼Æ÷
quiescent cell, Q cell
Á¤Áö¼¼Æ÷
A cell
A ¼¼Æ÷
B cell
B¼¼Æ÷(~ á¬øà)
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
principal reaction
ÁÖ¹ÝÀÀ(ñ«Úãëë).
principal series
ÁÖ°è¿(Ì¡ËËç).
principal strain
ÁÖº¯Çü(ñ«Ü¨û¡).
principal stress
ÁÖº¯Çü·Â, ÁÖÀÀ·Â(ñ«ëëæ³).
principal tangential line
ÁÖÁ¢¼±°î¼±(ñ«ïÈàÊÍØàÊ).
principal valency
ÁÖ¿øÀÚ°¡(ñ«ê«íʤ).
principal value of strain
¿ÖÁÖÄ¡(èàñ«öÇ).
alpha cell glucagon cell
¾ËÆÄ¼¼Æ÷ ±Û·çÄ«°ï¼¼Æ÷
beta cell insulin cell
º£Å¸¼¼Æ÷ Àν´¸°¼¼Æ÷
bronchiolar cell clara cell
¼¼±â°üÁö¼¼Æ÷
cell to cell cooperation
¼¼Æ÷°£ÇùÁ¶ÀÛ¿ë(á¬øàÊàúððàíÂéÄ).
chief cell type i glomus cell
°ú¸³¼¼Æ÷
clear cell basal cell carcinoma
Åõ¸í¼¼Æ÷ ±âÀú¼¼Æ÷¾Ï
clear cell epinephrine cell
¹àÀº¼¼Æ÷ ¿¡Çdz×ÇÁ¸°¼¼Æ÷
cytotoxic T-cell ; killer T-cell
(¼¼Æ÷)»ì(ÇØ) T¼¼Æ÷.
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½